121 related articles for article (PubMed ID: 38442582)
21. MicroRNA-29b-1 impairs in vitro cell proliferation, self‑renewal and chemoresistance of human osteosarcoma 3AB-OS cancer stem cells.
Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; D'Anneo A; Carlisi D; De Blasio A; Giuliano M; Tesoriere G; Giordano A; Vento R
Int J Oncol; 2014 Nov; 45(5):2013-23. PubMed ID: 25174983
[TBL] [Abstract][Full Text] [Related]
22. miR-200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer.
Tang H; Song C; Ye F; Gao G; Ou X; Zhang L; Xie X; Xie X
J Cell Mol Med; 2019 Dec; 23(12):8114-8127. PubMed ID: 31599500
[TBL] [Abstract][Full Text] [Related]
23. The inhibition of circular RNA circNOLC1 by propofol/STAT3 attenuates breast cancer stem cells function via miR-365a-3p/STAT3 signaling.
Liu YP; Heng JY; Zhao XY; Li EY
J Transl Med; 2021 Nov; 19(1):467. PubMed ID: 34789263
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA signature in the chemoprevention of functionally-enriched stem and progenitor pools (FESPP) by Active Hexose Correlated Compound (AHCC).
Graham ÉA; Mallet JF; Jambi M; Nishioka H; Homma K; Matar C
Cancer Biol Ther; 2017 Oct; 18(10):765-774. PubMed ID: 28886271
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of miR-29a reduces the oncogenic properties of glioblastoma stem cells by downregulating Quaking gene isoform 6.
Xi Z; Wang P; Xue Y; Shang C; Liu X; Ma J; Li Z; Li Z; Bao M; Liu Y
Oncotarget; 2017 Apr; 8(15):24949-24963. PubMed ID: 28212562
[TBL] [Abstract][Full Text] [Related]
26. miR-589-5p inhibits MAP3K8 and suppresses CD90
Zhang X; Jiang P; Shuai L; Chen K; Li Z; Zhang Y; Jiang Y; Li X
J Exp Clin Cancer Res; 2016 Nov; 35(1):176. PubMed ID: 27835990
[TBL] [Abstract][Full Text] [Related]
27. Tumorigenicity of cancer stem-like cells derived from hepatocarcinoma is regulated by microRNA-145.
Jia Y; Liu H; Zhuang Q; Xu S; Yang Z; Li J; Lou J; Zhang W
Oncol Rep; 2012 Jun; 27(6):1865-72. PubMed ID: 22378186
[TBL] [Abstract][Full Text] [Related]
28. Dicer-mediated miR-200b expression contributes to cell migratory/invasive abilities and cancer stem cells properties of breast cancer cells.
Hsu TW; Chen HA; Liao PH; Su YH; Chiu CF; Huang CY; Lin YJ; Hung CC; Yeh MH; Sung SY; Su CM
Aging (Albany NY); 2022 Aug; 14(16):6520-6536. PubMed ID: 35951366
[TBL] [Abstract][Full Text] [Related]
29. MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b.
Roscigno G; Quintavalle C; Donnarumma E; Puoti I; Diaz-Lagares A; Iaboni M; Fiore D; Russo V; Todaro M; Romano G; Thomas R; Cortino G; Gaggianesi M; Esteller M; Croce CM; Condorelli G
Oncotarget; 2016 Jan; 7(1):580-92. PubMed ID: 26556862
[TBL] [Abstract][Full Text] [Related]
30. miR-155 increases stemness and decitabine resistance in triple-negative breast cancer cells by inhibiting TSPAN5.
Yang LW; Wu XJ; Liang Y; Ye GQ; Che YC; Wu XZ; Zhu XJ; Fan HL; Fan XP; Xu JF
Mol Carcinog; 2020 Apr; 59(4):447-461. PubMed ID: 32096299
[TBL] [Abstract][Full Text] [Related]
31. miR-484 suppresses endocrine therapy-resistant cells by inhibiting KLF4-induced cancer stem cells in estrogen receptor-positive cancers.
Wei Y; Li H; Qu Q
Breast Cancer; 2021 Jan; 28(1):175-186. PubMed ID: 32865695
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.
Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C
Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor-β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM.
Wang Y; Yu Y; Tsuyada A; Ren X; Wu X; Stubblefield K; Rankin-Gee EK; Wang SE
Oncogene; 2011 Mar; 30(12):1470-80. PubMed ID: 21102523
[TBL] [Abstract][Full Text] [Related]
34. Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway.
Barnawi R; Al-Khaldi S; Majed Sleiman G; Sarkar A; Al-Dhfyan A; Al-Mohanna F; Ghebeh H; Al-Alwan M
Stem Cells; 2016 Dec; 34(12):2799-2813. PubMed ID: 27502039
[TBL] [Abstract][Full Text] [Related]
35. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
Bahena-Ocampo I; Espinosa M; Ceballos-Cancino G; Lizarraga F; Campos-Arroyo D; Schwarz A; Maldonado V; Melendez-Zajgla J; Garcia‐Lopez P
EMBO Rep; 2016 May; 17(5):648-58. PubMed ID: 27113763
[TBL] [Abstract][Full Text] [Related]
36. MiR-137 Suppresses Triple-Negative Breast Cancer Stemness and Tumorigenesis by Perturbing BCL11A-DNMT1 Interaction.
Chen F; Luo N; Hu Y; Li X; Zhang K
Cell Physiol Biochem; 2018; 47(5):2147-2158. PubMed ID: 29975921
[TBL] [Abstract][Full Text] [Related]
37. Glabridin inhibits cancer stem cell-like properties of human breast cancer cells: An epigenetic regulation of miR-148a/SMAd2 signaling.
Jiang F; Li Y; Mu J; Hu C; Zhou M; Wang X; Si L; Ning S; Li Z
Mol Carcinog; 2016 May; 55(5):929-40. PubMed ID: 25980823
[TBL] [Abstract][Full Text] [Related]
38. Circ_0072995 drives cervical cancer development by regulating the miR-29a/WDR5 axis.
Song Z; Li H
J Obstet Gynaecol; 2022 Oct; 42(7):3342-3348. PubMed ID: 36168936
[TBL] [Abstract][Full Text] [Related]
39. Long intergenic non-protein-coding RNA 1567 (LINC01567) acts as a "sponge" against microRNA-93 in regulating the proliferation and tumorigenesis of human colon cancer stem cells.
Yu X; Mi L; Dong J; Zou J
BMC Cancer; 2017 Nov; 17(1):716. PubMed ID: 29110645
[TBL] [Abstract][Full Text] [Related]
40. An integrated analysis to predict micro-RNAs targeting both stemness and metastasis in breast cancer stem cells.
Rahimi M; Sharifi-Zarchi A; Firouzi J; Azimi M; Zarghami N; Alizadeh E; Ebrahimi M
J Cell Mol Med; 2019 Apr; 23(4):2442-2456. PubMed ID: 30710426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
